ICN Pharmaceuticals Inc. said last week that...
- Share via
ICN Pharmaceuticals Inc. said last week that it raised approximately $32 million through the sale of subordinated convertible debentures in the Netherlands. Proceeds of the Eurobond offering, valued at 75 million Dutch guilders, will be used in part to finance acquisitions, the Costa Mesa drug maker said.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
